Insider Transactions Reported by 20 Insiders of Autolus Therapeutics plc

Symbol
AUTL on Nasdaq
Location
London, United Kingdom

There are no Buy or Sell transactions made by insiders since 19 Mar 2025

Autolus Therapeutics plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Miranda Suzette Neville Chief Technology Officer 18 Mar 2026
Alex Driggs SVP, Legal Affairs and GC 18 Mar 2026
Alexander Swan Chief Human Resources Officer 18 Mar 2026
Christopher Michael James Williams Chief Business Officer 18 Mar 2026
Christopher Andrew Vann Chief Operating Officer 18 Mar 2026
Martin Anton Pule Director 18 Mar 2026
Christian Itin Chief Executive Officer, Director 18 Mar 2026
John E. Berriman Director 18 Mar 2026
Robert Iannone Director 18 Mar 2026
Linda Bain Director 18 Mar 2026
Robert Dolski Chief Financial Officer 18 Mar 2026
Patrick Paul McIlvenny SVP Finance 18 Mar 2026
Michael W. Bonney Director 18 Mar 2026
Madduri Ravin Rao Director 18 Mar 2026
Robert Azelby Director 18 Mar 2026
William D. Young Director 18 Mar 2026
Matthias Will Chief Development Officer 18 Mar 2026
Elisabeth Leiderman Director 18 Mar 2026
Cynthia M. Butitta Director 18 Mar 2026
Cintia Piccina U.S. CCO & Country Gen Manager 18 Mar 2026

Recent Insider Transactions by Companies or Individuals for Autolus Therapeutics plc

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
John E. Berriman AUTL Ordinary Shares 0 136,331 18 Mar 2026 Direct
Christian Itin AUTL Ordinary Shares 0 1,116,009 18 Mar 2026 Direct
Christopher Andrew Vann AUTL Ordinary Shares 0 152,211 18 Mar 2026 Direct
Christopher Michael James Williams AUTL Ordinary Shares 0 8,198 18 Mar 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.